Hospice News February 24, 2022
LHC Group (NASDAQ: LHCG) is setting its strategic sights on “all things end-of-life care,” seeing growth potential in its hospice segment on the horizon. Spending much of the past years building up its hospice platform with acquisitions, the company aims to continue building momentum into the space during 2022.
In recent years LHC Group has remained bullish in the hospice market, but announced in 2021’s third quarter that it would pull back the reins in this space with a slowed focus on hospice ahead, according to CEO Keith Myers. Hospice deals made up just above 60% in cash flow set aside to further boost the company’s M&A pipeline during Q2 2021.
Last year was a “huge year” of acquisitions that...
Today's Sponsors
Today's Sponsor
Topics: Uncategorized